Swanbridge Capital invests in IPaDiC

Rotterdam, July 20th, 2018 – IPaDiC, a private company that aims to develop an implantable insulin pump, announced today that it has secured funding for the first phase of development. The funding allows IPaDiC to develop and validate a prototype of the insulin pump,...

Abegaill successfully closes seed funding round

Rotterdam, December 21th, 2017 – Abegaill B.V. announces the successfully closing of a seed funding round. This funding is provided by Swanbridge Capital, a Dutch life science venture capital fund, and Leander Healthcare, a Benelux medtech innovation provider. Edwin...

Swanbridge Capital leads investment round into FABPulous

Rotterdam, October 17th, 2017 – Swanbridge Capital, a Dutch Life Science Venture Capital fund, today announced its investment in FABPulous B.V., a Dutch start-up company focused on the development of a new diagnostic tool that quickly distinguishes whether patients...

Launch of €6.5 million Life Sciences Fund

Rotterdam, December 15, 2016 – Swanbridge Capital today announced the launch and closing of its first life science fund. The fund, with a size of €6.5 million, will invest in early stage life sciences ventures that require capital to fund their first Proof of...